Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 1467 entries
View as:

Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01308567 Org: User:
Start: 05/05/11 End: 05/31/18 Due: 05/31/19

Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01127269 Org: User:
Start: 05/31/10 End: 06/30/13 Due: 06/30/14

A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00399724 Org: User:
Start: 03/31/02 End: 08/31/03 Due: 08/31/04

Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01632163 Org: User:
Start: 10/31/12 End: 05/31/15 Due: 05/31/16

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02058160 Org: User:
Start: 01/31/14 End: 07/31/15 Due: 07/31/16

A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT05662319 Org: User:
Start: 02/01/23 End: 06/01/28 Due: 06/01/29

Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00220272 Org: User:
Start: 01/31/04 End: 03/31/07 Due: 03/31/08

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Phase: N/A Priority: Normal
NCT ID: NCT00976937 Org: User:
Start: 08/31/09 End: 03/31/11 Due: 03/31/12

Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax

Phase: N/A Priority: Normal
NCT ID: NCT00826852 Org: User:
Start: 10/31/03 End: 07/31/09 Due: 07/31/10

Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01576029 Org: User:
Start: 08/31/12 End: 12/31/13 Due: 12/31/14

Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)

Phase: N/A Priority: Normal
NCT ID: NCT00268671 Org: User:
Start: 08/31/03 End: 04/30/06 Due: 04/30/07

Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

Phase: N/A Priority: Normal
NCT ID: NCT00699920 Org: User:
Start: 06/30/08 End: 06/30/10 Due: 06/30/11

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT01718353 Org: User:
Start: 03/31/13 End: 08/31/15 Due: 08/31/16

An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00374166 Org: User:
Start: 08/31/06 End: 02/29/08 Due: 02/28/09

Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00481975 Org: User:
Start: 08/31/04 End: 08/31/05 Due: 08/31/06

Effect of Efpeglenatide on Cardiovascular Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03496298 Org: User:
Start: 04/27/18 End: 12/10/20 Due: 12/10/21

Lantus Versus Levemir Treat-To-Target

Phase: N/A Priority: Normal
NCT ID: NCT00405418 Org: User:
Start: 11/30/06 End: - Due: -

Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01448317 Org: User:
Start: 05/31/11 End: 01/31/12 Due: 01/31/13

Dermacyd Silver Floral (Lactic Acid) - Compatibility.

Phase: N/A Priority: Normal
NCT ID: NCT00933712 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT00847834 Org: User:
Start: 12/31/03 End: - Due: -

Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Phase: N/A Priority: Normal
NCT ID: NCT00264927 Org: User:
Start: 05/31/04 End: 09/30/07 Due: 09/30/08

Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00409357 Org: User:
Start: 11/30/04 End: 08/31/05 Due: 08/31/06

ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00316329 Org: User:
Start: 03/31/06 End: - Due: -

Oxaliplatin in Esophagus Cancer (Advanced) 1st Line

Phase: N/A Priority: Normal
NCT ID: NCT00259402 Org: User:
Start: 02/29/00 End: 10/31/08 Due: 10/31/09

Registry for Stage 2 Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06481904 Org: User:
Start: 09/27/24 End: 01/15/37 Due: 01/15/38